Soros Fund Management - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 39 filers reported holding TRANSPHORM INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$754,800
-48.4%
340,000
-20.9%
0.01%
-52.2%
Q2 2023$1,462,000
-42.7%
430,000
-32.8%
0.02%
-41.0%
Q1 2023$2,552,882
-30.4%
639,820
-5.1%
0.04%
-22.0%
Q4 2022$3,666,511
+8.2%
673,9910.0%0.05%
-13.8%
Q3 2022$3,390,000
+32.0%
673,9910.0%0.06%
+26.1%
Q2 2022$2,568,000
-46.1%
673,9910.0%0.05%
-36.1%
Q1 2022$4,765,000673,9910.07%
Other shareholders
TRANSPHORM INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,772,875$18,978,0005.90%
Worth Venture Partners, LLC 911,237$4,584,0002.81%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$114,060,0002.29%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,944$1,262,0001.37%
Soros Fund Management 673,991$3,390,0000.06%
Polar Asset Management Partners Inc. 709,700$3,570,0000.04%
AMERIPRISE FINANCIAL INC 3,805,595$19,142,0000.01%
Stratos Wealth Partners, LTD. 30,000$151,0000.00%
FMR LLC 886$4,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,801$54,0000.00%
View complete list of TRANSPHORM INC shareholders